GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)

HKG:2595 Revenue

GenFleet Therapeutics (Shanghai) had revenue of 42.47M CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 84.00M, down -56.58% year-over-year. In the year 2025, GenFleet Therapeutics (Shanghai) had annual revenue of 130.27M with 24.42% growth. That makes GenFleet Therapeutics (Shanghai) the 36,439th largest company in the world by revenue and 2,206th in Hong Kong.

• Revenue (ttm): 84.00M CNY
• Revenue Growth: -56.58%
• P/S Ratio: 91.28
• Revenue / Employee: 528.28K CNY
• Employees: 159
• Market Cap: 8.87B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	130.27M	25.56M	24.42%
Dec 31, 2024	104.70M	30.97M	42.00%
Dec 31, 2023	73.73M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 6, 2026

Data Sources Report a data error